Clinical Trial Detail

NCT ID NCT02240238
Title Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd.
Indications

biliary tract cancer

urethra transitional cell carcinoma

lung squamous cell carcinoma

cholangiocarcinoma

ampulla of Vater carcinoma

gallbladder cancer

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Advanced Solid Tumor

Therapies

Gemcitabine + NC-6004

Age Groups: senior adult

No variant requirements are available.